Summit Therapeutics (NASDAQ:SMMT) Issues Quarterly Earnings Results, Beats Estimates By $0.03 EPS
Summit Therapeutics (NASDAQ:SMMT – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.24) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.03, Zacks reports. Summit Therapeutics Trading Down 24.9% NASDAQ SMMT traded down $5.35 during trading on Friday, reaching $16.11. The company’s stock had […]
2 May 15:54 · The Cerbat Gem